These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 12402286

  • 1. Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells.
    Langenbach KJ, Rando TA.
    Muscle Nerve; 2002 Nov; 26(5):644-53. PubMed ID: 12402286
    [Abstract] [Full Text] [Related]

  • 2. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
    Chandrasekher G, Sailaja D.
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
    [Abstract] [Full Text] [Related]

  • 3. Regulation of phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch.
    Dogra C, Changotra H, Wergedal JE, Kumar A.
    J Cell Physiol; 2006 Sep; 208(3):575-85. PubMed ID: 16741926
    [Abstract] [Full Text] [Related]

  • 4. Decreases in phosphoinositide-3-kinase/Akt and extracellular signal-regulated kinase 1/2 signaling activate components of spinal motoneuron death.
    Newbern J, Taylor A, Robinson M, Li L, Milligan CE.
    J Neurochem; 2005 Sep; 94(6):1652-65. PubMed ID: 16045454
    [Abstract] [Full Text] [Related]

  • 5. Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex.
    Sciandra F, Bozzi M, Bianchi M, Pavoni E, Giardina B, Brancaccio A.
    Ann Ist Super Sanita; 2003 Sep; 39(2):173-81. PubMed ID: 14587215
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.
    Côté PD, Moukhles H, Lindenbaum M, Carbonetto S.
    Nat Genet; 1999 Nov; 23(3):338-42. PubMed ID: 10610181
    [Abstract] [Full Text] [Related]

  • 8. SHP-2 regulates the phosphatidylinositide 3'-kinase/Akt pathway and suppresses caspase 3-mediated apoptosis.
    Ivins Zito C, Kontaridis MI, Fornaro M, Feng GS, Bennett AM.
    J Cell Physiol; 2004 May; 199(2):227-36. PubMed ID: 15040005
    [Abstract] [Full Text] [Related]

  • 9. The role of dystroglycan, a novel receptor of laminin and agrin, in cell differentiation.
    Matsumura K, Yamada H, Saito F, Sunada Y, Shimizu T.
    Histol Histopathol; 1997 Jan; 12(1):195-203. PubMed ID: 9046055
    [Abstract] [Full Text] [Related]

  • 10. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt.
    McDaneld TG, Spurlock DM.
    J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171
    [Abstract] [Full Text] [Related]

  • 11. Sarcoglycans in muscular dystrophy.
    Hack AA, Groh ME, McNally EM.
    Microsc Res Tech; 2008 Nov; 48(3-4):167-80. PubMed ID: 10679964
    [Abstract] [Full Text] [Related]

  • 12. Deficiency of alpha-dystroglycan in muscle-eye-brain disease.
    Kano H, Kobayashi K, Herrmann R, Tachikawa M, Manya H, Nishino I, Nonaka I, Straub V, Talim B, Voit T, Topaloglu H, Endo T, Yoshikawa H, Toda T.
    Biochem Biophys Res Commun; 2002 Mar 15; 291(5):1283-6. PubMed ID: 11883957
    [Abstract] [Full Text] [Related]

  • 13. Altered caveolin-3 expression disrupts PI(3) kinase signaling leading to death of cultured muscle cells.
    Smythe GM, Rando TA.
    Exp Cell Res; 2006 Sep 10; 312(15):2816-25. PubMed ID: 16814768
    [Abstract] [Full Text] [Related]

  • 14. Muscular dystrophy associated with beta-Dystroglycan deficiency.
    Salih MA, Sunada Y, Al-Nasser M, Ozo CO, Al-Turaiki MH, Akbar M, Campbell KP.
    Ann Neurol; 1996 Dec 10; 40(6):925-8. PubMed ID: 9007100
    [Abstract] [Full Text] [Related]

  • 15. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy.
    Moore SA, Saito F, Chen J, Michele DE, Henry MD, Messing A, Cohn RD, Ross-Barta SE, Westra S, Williamson RA, Hoshi T, Campbell KP.
    Nature; 2002 Jul 25; 418(6896):422-5. PubMed ID: 12140559
    [Abstract] [Full Text] [Related]

  • 16. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
    Matsumura K, Campbell KP.
    Muscle Nerve; 1994 Jan 25; 17(1):2-15. PubMed ID: 8264699
    [Abstract] [Full Text] [Related]

  • 17. Suppression of apoptosis by UVB irradiation: survival signaling via PI3-kinase/Akt pathway.
    Ibuki Y, Goto R.
    Biochem Biophys Res Commun; 2000 Dec 29; 279(3):872-8. PubMed ID: 11162442
    [Abstract] [Full Text] [Related]

  • 18. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.
    Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, Nishino I, Kelley RI, Somer H, Straub V, Mathews KD, Moore SA, Campbell KP.
    Nature; 2002 Jul 25; 418(6896):417-22. PubMed ID: 12140558
    [Abstract] [Full Text] [Related]

  • 19. DNA-fragmentation and expression of apoptosis-related proteins in muscular dystrophies.
    Tews DS, Goebel HH.
    Neuropathol Appl Neurobiol; 1997 Aug 25; 23(4):331-8. PubMed ID: 9292873
    [Abstract] [Full Text] [Related]

  • 20. Dystrophin glycoprotein complex-associated Gbetagamma subunits activate phosphatidylinositol-3-kinase/Akt signaling in skeletal muscle in a laminin-dependent manner.
    Xiong Y, Zhou Y, Jarrett HW.
    J Cell Physiol; 2009 May 25; 219(2):402-14. PubMed ID: 19117013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.